Showing results (241-250 of 1,410) with videos related to
Sort By:
Pageof 141
BMJ Open Respiratory Research|June 5, 2025
Bronchoscopic lung volume reduction: model for assisted target lobe selectionLogan Hostetter, Leah M Brown, Srinivasan Rajagopalan, et al.BMJ Open Respiratory Research|February 19, 2024
Respiratory symptoms, exacerbations and sleep disturbances are more common among participants with asthma and chronic airflow limitation: an epidemiological study in Estonia, Iceland and SwedenStephanie Mindus, Thorarinn Gislason, Bryndis Benediktsdottir, et al.BMJ Open Respiratory Research|February 22, 2024
Chronic obstructive pulmonary disease trajectory: severe exacerbations and dynamic change in health-related quality of lifeSheng-Han Tsai, Jo-Ying Hung, Pei-Fang Su, et al.BMJ Open Respiratory Research|February 22, 2024
Hospitalisations and fatality due to respiratory diseases according to a national database in Brazil: a longitudinal studyDarllane Azevedo Lemos, Luiza Gabriela de Araújo Fonseca, Rencio Bento Florêncio, et al.BMJ Open Respiratory Research|February 20, 2024
Remote pulmonary rehabilitation for interstitial lung disease: developing the model using experience-based codesignLisa Jane Brighton, Nannette Spain, Jose Gonzalez-Nieto, et al.BMJ Open Respiratory Research|February 27, 2024
Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseasesCuirong Ba, Huijuan Wang, Chunguo Jiang, et al.BMJ Open Respiratory Research|February 23, 2024
Association of non-obstructive dyspnoea with all-cause mortality and incident chronic obstructive pulmonary disease: a systematic literature review and meta-analysisYuyan Hou, Fan Wu, Huanhuan Fan, et al.BMJ Open Respiratory Research|February 23, 2024
Association between pulmonary function and rapid kidney function decline: a longitudinal cohort study from CHARLSShisheng Han, Yanqiu Xu, Yi WangBMJ Open Respiratory Research|April 4, 2024
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort studyMyriam Drysdale, Evgeniy R Galimov, Marcus James Yarwood, et al.BMJ Open Respiratory Research|April 5, 2024
Unveiling the truth: is COVID-19 reimbursement in Colombia a flawed design? A cost-of-illness analysis for moderate, severe and critical infectionsLiliana Fernandez-Trujillo, Saveria Sangiovanni, Ana Isabel Castrillon, et al.Pageof 141